MSF Access Campaign
MSF is disappointed with the inadequate outcome after nearly two years of discussions at the WTO
MSF responds to new WHO guidance recommending vastly shorter, improved and better-tolerated treatment for multi drug-resistant TB
Access to medicines: MSF applauds US’ leadership on waiving IP for COVID-19 vaccines
Access to medicines: Five people, five reasons we need to overcome monopolies on medicines
COVID-19: Pfizer and Moderna vaccines can only be scaled up globally if many more suppliers can produce
5 reasons a new proposal by India and South Africa could be a gamechanger in the COVID-19 response
Access to Medicines: In landmark move, India and South Africa propose no patents on COVID-19 medicines, tools during pandemic
MSF: Any future COVID-19 vaccines must be sold at cost and accessible to all
Access to medicines: MSF demands review of USTR Special 301 report on trade barriers
